AI assistant
Sending…
Twist Bioscience Corp — Director's Dealing 2021
Mar 5, 2021
31873_dirs_2021-03-05_035be0d6-bf0c-4e4a-8e2e-d1d0cad762c5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2019-07-23
Reporting Person: JOHANNESSEN JAN (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-07-23 | Director Stock Option (right to buy) | $30.41 | A | 10588 | Acquired | 2029-07-22 | Common Stock (10588) | Direct |
Footnotes
F1: The Form 4 originally filed on October 9,2019 incorrectly reported 5,590 options.
F2: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date.
More from Twist Bioscience Corp
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 17
Interim / Quarterly Report
2026
Feb 26
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25